These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 22903047)
1. Development and evaluation of sustained-release clonidine-loaded PLGA microparticles. Gaignaux A; Réeff J; Siepmann F; Siepmann J; De Vriese C; Goole J; Amighi K Int J Pharm; 2012 Nov; 437(1-2):20-8. PubMed ID: 22903047 [TBL] [Abstract][Full Text] [Related]
2. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
3. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization. Xu H; Zhong H; Liu M; Xu C; Gao Y Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119 [TBL] [Abstract][Full Text] [Related]
4. Entrapment and release kinetics of furosemide from pegylated nanocarriers. Youm I; Murowchick JB; Youan BB Colloids Surf B Biointerfaces; 2012 Jun; 94():133-42. PubMed ID: 22386795 [TBL] [Abstract][Full Text] [Related]
5. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. Kim JH; Taluja A; Knutson K; Han Bae Y J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769 [TBL] [Abstract][Full Text] [Related]
6. Enhanced targeting efficiency of PLGA microspheres loaded with Lornoxicam for intra-articular administration. Zhang Z; Bi X; Li H; Huang G Drug Deliv; 2011; 18(7):536-44. PubMed ID: 21812757 [TBL] [Abstract][Full Text] [Related]
7. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters. Chaisri W; Ghassemi AH; Hennink WE; Okonogi S Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499 [TBL] [Abstract][Full Text] [Related]
8. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. Duvvuri S; Janoria KG; Mitra AK J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919 [TBL] [Abstract][Full Text] [Related]
9. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
10. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro. Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P Int J Pharm; 2004 Jul; 279(1-2):33-41. PubMed ID: 15234792 [TBL] [Abstract][Full Text] [Related]
12. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release. Song X; Song SK; Zhao P; Wei LM; Jiao HS Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954 [TBL] [Abstract][Full Text] [Related]
13. Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres. Chen W; Palazzo A; Hennink WE; Kok RJ Mol Pharm; 2017 Feb; 14(2):459-467. PubMed ID: 27973854 [TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique. Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816 [TBL] [Abstract][Full Text] [Related]
15. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles. Klose D; Delplace C; Siepmann J Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644 [TBL] [Abstract][Full Text] [Related]
16. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. Bae SE; Son JS; Park K; Han DK J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification. Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891 [TBL] [Abstract][Full Text] [Related]
18. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres. Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486 [TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445 [TBL] [Abstract][Full Text] [Related]
20. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques. Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]